MHS
ABEO icon

M Holdings Securities’s Abeona Therapeutics ABEO Stock Holding History

M Holdings Securities’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,472
Closed -$8K – 434
2022
Q2 		$8K Hold
1,472
– – ﹤0.01% 438
2022
Q1 		$12K Buy
+1,472
New +$10.1K ﹤0.01% 501

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

M Holdings Securities's ABEO Position: Q3 2022 in Review

M Holdings Securities sold out of Abeona Therapeutics (ABEO) in Q3 2022, closing a stake of 1,472 shares — an estimated $8K sold.

M Holdings Securities first reported a position in ABEO in Q1 2022 and held it in 2 quarters. The position peaked at $12K in Q1 2022. 24 funds tracked by Wall St. Rank hold ABEO as of Q3 2022.

  • M Holdings Securities reported no remaining Abeona Therapeutics position as of Q3 2022 after selling out during the quarter.
  • M Holdings Securities sold 1,472 Abeona Therapeutics shares in Q3 2022, an estimated $8K.
  • M Holdings Securities first reported a position in Abeona Therapeutics in Q1 2022 and held it in 2 quarters.
  • M Holdings Securities's Abeona Therapeutics position peaked at $12K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2022.

Based on M Holdings Securities's 13F filing for Q3 2022, filed 17 Nov 2022.